FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,117 letters match. Newest first.
-
DrugsNingbo Poplar Daily-Use
FDA warned Ningbo Poplar Daily-Use that its OTC drugs had manufacturing quality failures in testing, component identity checks, and stability data.
High risk -
DrugsMadhu Instruments Private Limited
FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
FoodLucky K.T. Co., Inc.
FDA warns Lucky K.T. noodle maker over insanitary conditions, missing food safety plan, undeclared wheat.
High risk -
FoodCurtis Jacquot dba Pacific BioLogic Co.
Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.
High risk -
FoodPerfection Bakeries Inc., dba Aunt Millie’s Bakeries
Perfection Bakeries, dba Aunt Millie’s, recalled Our Family white hot dog buns because the label did not declare sesame.
High risk -
FoodBattle Creek Co-op/CHS, LLC dba Progressive Nutrition
Progressive Nutrition's cattle feed contained excess urea linked to 17 cattle deaths, with preventive-control and medicated-feed violations.
High risk -
DrugsLes Importations Herbasanté Inc.
Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.
High risk -
FoodInmar Supply Chain Solutions, LLC
FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.
High risk -
DrugsNantong Furuida Packaging Products Co., Ltd.
Nantong Furuida, an over-the-counter drug manufacturer, failed required manufacturing controls and methanol checks, leading to an FDA import alert.
High risk -
DrugsS & J International Enterprises Public Company Limited
FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.
High risk -
DrugsMei Lan Thailand Co., Ltd.
Mei Lan Thailand, an API drug manufacturer, refused an FDA inspection and was placed on Import Alert 55-03.
High risk -
DrugsGlicerinas Industriales, S.A. de C.V.
FDA warned Glicerinas Industriales over CGMP failures in repackaged glycerin and propylene glycol, including DEG/EG testing and particulate contamination.
High risk -
FoodReConserve Inc.
FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.
High risk -
FoodComercializadora Internacional Piscicola New Your S.A
Colombian tilapia processor's HACCP plan omits Clostridium botulinum and drug-residue hazards, FDA says after remote assessment.
High risk -
DrugsPrime Lab LLC
Prime Lab LLC failed U.S. drug manufacturing quality rules for over-the-counter hand soaps and sanitizers, including raw-material testing and shared toxic equipment.
High risk -
DrugsWoorilife & Health
Woorilife & Health, a South Korean OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
BiologicsMiMedx Group, Inc.
FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.
High risk -
DevicesDeymed Diagnostic s.r.o.
Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.
Medium -
BiologicsKimera Labs, Inc.
FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.
High risk -
DrugsInopak, Ltd.
Inopak, Ltd. was warned of CGMP (current good manufacturing practice) violations after inspection: poor quality oversight of contract-made hand sanitizer and missing stability testing.
High risk -
FoodLone Star Botanicals Inc.
FDA cited Lone Star Botanicals for unsanitary ready-to-eat seasonings and unapproved drug claims for Dr. Botanical Health products.
High risk -
DrugsWipro Unza Singapore Private, Limited
FDA cites Wipro Unza Singapore for refusing OTC hand sanitizer records, leading to import alert.
High risk -
DrugsPatcos Cosmetics Pvt. Ltd.
Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
DrugsOmeza LLC
FDA warned Omeza LLC over mold, insects and animal waste in drug manufacturing areas and unapproved nonprescription drugs.
High risk -
DrugsDextrum Laboratories Inc.
FDA found Dextrum Laboratories, an over-the-counter drug contract manufacturer, failed identity testing, toxic glycol checks, water monitoring, and process validation.
High risk -
FoodUS Gulf Coast Trading Co., Inc.
US Gulf Coast Trading Co. warehouse in Houston held food amid widespread rodent filth and insanitary conditions.
High risk -
DrugsColonial Dames Company, Ltd
FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.
High risk -
FoodCooperstown Cheese Company, LLC
FDA found Listeria monocytogenes in Cooperstown Cheese's ready-to-eat raw milk cheese facility and cited repeated sanitation failures.
High risk -
DrugsSudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi
FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.
High risk -
DevicesTerragene S.A.
Terragene S.A. made sterilization indicator devices with complaint-handling and MDR failures and uncleared extended-cycle claims.
High risk -
DevicesSonesta Medical AB
FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.
Medium -
FoodDesserts by Helen, Inc.
FDA cited Desserts by Helen for unsanitary conditions and cleaning failures at its Louisville ready-to-eat bakery.
High risk -
DevicesFresenius Medical Care AG & Co. KGaA
FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.
High risk -
DrugsNovid Group, Inc.
FDA told Novid Group its OTC nasal spray, novid NASAL SPRAY, is an unapproved new drug and misbranded.
High risk -
FoodNutra Blend, LLC subsidiary of Land O’Lakes
Nutra Blend's medicated calf feed contained unintended monensin, killing calves and prompting a recall.
High risk -
DrugsDr. Berne’s Whole Health Products
Dr. Berne’s MSM eye drops and mist are unapproved new drugs; a tested lot had microbial contamination.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.
High risk -
DrugsAmLion Toothpaste Mfg. Sdn. Bhd.
FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.
High risk -
DrugsCipla Limited
FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.
High risk -
DrugsCerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi
FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.
High risk -
DrugsXiamen Wally Bath Manufacture Co., Ltd.
FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.
High risk -
FoodWan-Gee Foods, Inc.
FDA found insanitary conditions and missing food safety controls at Wan-Gee Foods’ noodle plant.
High risk -
DrugsNational Chemical Laboratories
National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.
High risk -
DrugsBrenntag Great Lakes, LLC
Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.
High risk -
DrugsElemental Herbs Inc. d/b/a ALL good
Elemental Herbs (ALL good) cited for CGMP failures and unapproved, misbranded Goop Skin Recovery Balm.
High risk -
DevicesWello Inc.
FDA cited Wello Inc. for misbranded welloStationX devices because labels lacked unique device identifiers and required GUDID data were not submitted.
Low -
DrugsSaruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi
FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.
High risk -
FoodIndependent Seafoods Panama, S.A. dba Panama Artisanal Seafoods FQ
FDA warned Independent Seafoods Panama over missing written seafood safety plans for fresh and histamine fish.
High risk -
FoodPESCAMOZ LDA
FDA says PESCAMOZ lacked required seafood safety plans for tuna and swordfish, calling products adulterated.
High risk